Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study.


Journal

Cardiovascular drugs and therapy
ISSN: 1573-7241
Titre abrégé: Cardiovasc Drugs Ther
Pays: United States
ID NLM: 8712220

Informations de publication

Date de publication:
08 2022
Historique:
accepted: 21 02 2021
pubmed: 9 4 2021
medline: 14 7 2022
entrez: 8 4 2021
Statut: ppublish

Résumé

Wire-based coronary physiology pullback performed before percutaneous coronary intervention (PCI) discriminates coronary artery disease (CAD) distribution and extent, and is able to predict functional PCI result. No research investigated if quantitative flow ratio (QFR)-based physiology assessment is able to provide similar information. In 111 patients (120 vessels) treated with PCI, QFR was measured both before and after PCI. Pre-PCI QFR trace was used to discriminate functional patterns of CAD (focal, serial lesions, diffuse disease, combination). Functional CAD patterns were identified analyzing changes in the QFR virtual pullback trace (qualitative method) or after computation of the QFR virtual pullback index (QVP By qualitative method, 51 (43%), 20 (17%), 15 (12%), and 34 (28%) vessels were classified as focal, serial focal lesions, diffuse disease, and combination, respectively. QVP Our results suggest that functional patterns of CAD based on pre-PCI QFR trace can predict the functional outcome after PCI. ClinicalTrials.gov , number NCT02811796. Date of registration: June 23, 2016.

Identifiants

pubmed: 33830399
doi: 10.1007/s10557-021-07162-6
pii: 10.1007/s10557-021-07162-6
pmc: PMC9270302
doi:

Banques de données

ClinicalTrials.gov
['NCT02811796']

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

645-653

Informations de copyright

© 2021. The Author(s).

Références

Circ Cardiovasc Interv. 2018 Feb;11(2):e006023
pubmed: 29449325
Circ Cardiovasc Interv. 2019 Feb;12(2):e007030
pubmed: 30732469
JACC Cardiovasc Interv. 2020 Nov 23;13(22):2670-2684
pubmed: 33069650
JACC Cardiovasc Imaging. 2021 Sep;14(9):1846-1855
pubmed: 33248968
JACC Cardiovasc Interv. 2018 Aug 13;11(15):1482-1491
pubmed: 29803695
Catheter Cardiovasc Interv. 2021 Mar;97(4):614-622
pubmed: 32845067
J Am Coll Cardiol. 2019 Oct 8;74(14):1772-1784
pubmed: 31582137
JACC Cardiovasc Interv. 2020 Nov 23;13(22):2688-2698
pubmed: 33129819
JACC Cardiovasc Interv. 2019 Oct 28;12(20):2079-2088
pubmed: 31563688
J Am Heart Assoc. 2018 Jul 6;7(14):
pubmed: 29980523

Auteurs

Simone Biscaglia (S)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Via Aldo Moro 8, 44124, Cona, FE, Italy. bscsmn@unife.it.

Barry F Uretsky (BF)

Central Arkansas VA Health System, Little Rock, AR, USA.

Matteo Tebaldi (M)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Via Aldo Moro 8, 44124, Cona, FE, Italy.

Andrea Erriquez (A)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Via Aldo Moro 8, 44124, Cona, FE, Italy.

Salvatore Brugaletta (S)

University Hospital Clínic, Cardiovascular Clinic Institute, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Enrico Cerrato (E)

San Luigi Gonzaga University Hospital, Orbassano and Infermi Hospital, Rivoli, Turin, Italy.

Giorgio Quadri (G)

San Luigi Gonzaga University Hospital, Orbassano and Infermi Hospital, Rivoli, Turin, Italy.

Giosafat Spitaleri (G)

University Hospital Clínic, Cardiovascular Clinic Institute, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Iginio Colaiori (I)

Interventional Cardiology Unit, S. Maria Nuova Hospital, Reggio Emilia, Italy.

Domenico Di Girolamo (D)

Casa di Cura San Michele, Maddaloni, CS, Italy.

Alessandra Scoccia (A)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Via Aldo Moro 8, 44124, Cona, FE, Italy.

Ottavio Zucchetti (O)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Via Aldo Moro 8, 44124, Cona, FE, Italy.

Emanuele D'Aniello (E)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Via Aldo Moro 8, 44124, Cona, FE, Italy.

Marco Manfrini (M)

GVM Care & Research, Maria Cecilia Hospital, Cotignola, RA, Italy.

Rita Pavasini (R)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Via Aldo Moro 8, 44124, Cona, FE, Italy.

Emanuele Barbato (E)

Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.
Cardiovascular Research Center, OLV Hospital, Aalst, Belgium.

Gianluca Campo (G)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Via Aldo Moro 8, 44124, Cona, FE, Italy.
GVM Care & Research, Maria Cecilia Hospital, Cotignola, RA, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH